Anxiolytic-like effects of a new 1-N substituted analog of melatonin in pinealectomized rats.

In spite of the wide variety of drugs available for treating anxiety, this disorder continues to represent a worldwide health problem that is classified within the first 10 causes of disability. Therefore, the search continues for new antianxiety agents, particularly those not related to benzodiazepines. Even though melatonin has been prescribed as an… CONTINUE READING